Other health services
BIRK NORDIC PHARMA CONSULTING AS
Revenue 2025
NOK 9.5m
Operating profit
NOK −1.4m
Equity
NOK 1.6m
Incorporated
2016
Share capital
NOK 40,000
Key figures · 2025
Current ratio
1.53
Equity ratio
40.7%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -15.3% | |
| Net margin (%%) | -17.1% | |
| Return on assets (%%) | -37.7% | |
| Likviditet | ||
| Current ratio | 1.53 | |
| Working capital | 1.2m | |
| Soliditet | ||
| Equity ratio (%%) | 40.7% | |
| Debt-to-equity ratio | 1.45 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.